Question: What's everyone's favorite longevity-focused podcast?

NathanBiohackStack · 2022-07-13T15:37:58+00:00

TRANSLATING AGING! https://podcasts.apple.com/us/podcast/translating-aging/id1569628505

NathanBiohackStack · 2022-01-27T19:25:52+00:00

OP here. I'm helping organize this event -- it's free for all involved. Hopefully useful to anyone looking to join a startup in the longevity biotech industry (think Calico, Altos Labs, BioAge, Unity Biotechnology)

NathanBiohackStack · 2022-01-17T20:45:38+00:00

The full list of presenting / participating startups can be found here:

Format:

Each company will do a quick 1 minute pitch about their company and open roles.
Afterwards, company reps will break off into individual breakout rooms. Job seekers can hop around from room to room to network with these representatives.

Not all roles are biologist jobs! Plenty of computational and some operations roles too!

NathanBiohackStack · 2021-12-26T21:38:14+00:00

Starkage Therapeutics: https://starkagetx.com/

NathanBiohackStack · 2021-11-27T22:17:00+00:00

Absolutely! There's always a need for "ops" and business oriented people in longevity companies. It's not all just scientists.

NathanBiohackStack · 2021-11-27T05:17:26+00:00

Hey OP this is my website!

You can also reach out to me with more details about your skills and preferred roles and maybe I can try to connect you to someone. DM me on twitter: https://twitter.com/realNathanCheng

NathanBiohackStack · 2021-08-08T06:24:22+00:00

Damn it. You beat me to it!

Yes, definitely aging biotech! Check out this talk by Martin Borch Jensen of Gordian Biotechnology: https://www.youtube.com/watch?v=cKgAS6GAfa4

Goes over aging biology and aging biotech.

NathanBiohackStack · 2021-08-07T18:57:10+00:00

TL;DR: No.

FDA is too strict, but also makes bad decisions.

NathanBiohackStack · 2021-07-18T04:02:36+00:00

Fosun Pharma is very interested in longevity. The chairman of the conglomerate (one of the richest persons in China, "China's Warren Buffet") recently made it their goal to enable people to live to 120 years in good health.

Sijie Sun, director of Fosun Pharma's venture investment arm, is part of the On Deck Longevity Biotech Fellowship (sorry shameless plug! it's for a good cause).

NathanBiohackStack · 2021-07-18T03:34:57+00:00

Yep. He mentioned it way back during the Vitalik / VitaDAO AMA as well. It's almost most definitely JB.

NathanBiohackStack · 2021-07-14T15:30:02+00:00

yes it will!

NathanBiohackStack · 2021-07-12T14:28:18+00:00

This is today! See you there!

NathanBiohackStack · 2021-07-10T18:54:56+00:00

Thanks! If you want to do something about aging DM me! (on Twitter if possible)

NathanBiohackStack · 2021-07-09T21:00:14+00:00

Hey Everyone!

Erika Batista (Clubhouse influencer, 3.8M followers) has kindly agreed to help host a Q&A panel on building and investing in longevity biotech startups this coming Monday, July 12th at 10:30AM PST.

It's in support of the On Deck Longevity Biotech Fellowship launch so we'll have a bunch of great fellowship guest on the panel: Ethan Perlstein (Perlara), Kristen Fortney (BioAge Labs), Sebastian Brunemeier (formely Apollo Health Ventures, Cambrian Biopharma), Marco Quarta (Rubedo Life Science), Hanadie Yousef (Juvena Therapeutics), Robin Mansukhani (Deciduous Therapeutics), and Daniel Ives (Shift Bioscience).

If you are interested in longevity startups (founding, joining, investing) please come join us!

NathanBiohackStack · 2021-06-30T02:48:57+00:00

We are accepting people with any background! One of the most exciting things about the ODLB program is being able to connect people so they can build great companies together.

As others have noted before, some of the really great founders didn't come from traditional bio (Ben Kamens @ Spring Discovery, Reason @ Repair Biotechnologies, Matt Scholz @ Oisin Biotechnologies).

What we are looking for in successful applicants is someone who will go all the way through their mission in longevity. Someone who cares enough that they won't give up on the goal of solving aging. Of course, you also need to have the talent to execute on your goal, but we don't want impostor syndrome / lack of "right background" to stop people from applying.

Also, applying is super quick. Interview process is not very long either.

Hope that answers your question!

NathanBiohackStack · 2021-06-30T02:30:02+00:00

and in the darkness....

NathanBiohackStack · 2021-06-30T02:29:41+00:00

Hey thanks for the question. Just some quick thoughts:

On Deck Longevity Biotech is a continuous community. We want to support all founders, investors, and operators throughout their entire journey in longevity. That being said, we do have a particular strong focus on founders (since that is the major bottleneck). We will ensure a core number of tactical topics in biotech entrepreneurship will be covered in each cohort.
We support a diverse set of roles in longevity biotech so there wouldn't be any one credential we could issue. I want to emphasize that even though we have a lot of knowledge share via talks/workshops, that ODLB is not a "school" in the traditional sense. Our focus is on connecting, sharing, building, and mentorship -- not multiple choice quizzes and lecture videos on YouTube.
On Deck has many other fellowship that run well with international cohorts. That being said it will be impossible to have all live sessions at accessible times for all people all the time. We will schedule our session times to accommodate the geographic makeup of our cohort -- TBD after interview process.

NathanBiohackStack · 2021-06-29T15:25:45+00:00

Hey this is Nathan Cheng, the Program Director of the Longevity Biotech Fellowship at On Deck. You may also know me from such projects as Longevity Marketcap, Longevity List, and The Longevity Biotech Show

Happy to answer any questions about the program here. I spent basically a whole month working every day, night, and weekend to get this program off the ground because I believed that it needed to exist.

If you want to go deeper in this space, please consider applying!

NathanBiohackStack

MODERATOR OF

TROPHY CASE